Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Taxotere
Active Ingredient: Docetaxel trihydrate 40mg/mL
Dosage Form: Solution for concentrate for infusion
New Zealand Sponsor: Aventis Pharma Limited
Manufacturers: Aventis Pharma, Dagenham, Essex, United Kingdom
Aventis Principes Actifs Pharmaceutiques, Guesde, Vitry-sur-Seine, France
Note: This consent is valid for two years from 23 May 2004.
Dated this 19th day of April 2004.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the
6th day of July 2001).